BAP Officer Details
Honorary General Secretary
Dr Peter Talbot
University of Manchester
Honorary General Secretary until 2021
I qualified in Medicine from the University of Bristol, and completed my specialist clinical training and MD in Psychiatry in Northern Ireland, the country of my birth. My postdoctoral research training was in Positron Emission Tomography (PET) neuroimaging under the supervision of Marc Laruelle at Columbia University in New York, followed by appointment as Assistant Professor in Psychiatry there in 2004. I joined the University of Manchester in 2005 and am currently Senior Lecturer in Molecular Neuroimaging and Associate Director of the Wolfson Molecular Imaging Centre. My primary research interest is the use of PET to investigate abnormal brain mechanisms in severe mental illness, particularly psychosis, affective disorders and impulsivity. I am active in neuroscience and psychopharmacology teaching both locally (Lead for undergraduate and postgraduate modules; President, Manchester Medical Society Psychiatry Division) and nationally for the BAP (Course Organiser for the Schizophrenia Module 2013-2017; lecturer on the Affective Disorders Module and Depression Masterclass). I am an Honorary Consultant Psychiatrist with Greater Manchester Mental Health NHS Foundation Trust, and until July 2019 I was Director of the Specialist Service for Affective Disorders, a regional tertiary-level NHS clinic.
I have been an active member of BAP for over 18 years (BAP Certificate in Psychopharmacology, 2001), serving on Council since 2015. Throughout my training I found the BAP’s Education & Training programmes invaluable and as a researcher I greatly value the Summer Meeting as an opportunity to share cutting edge research with clinical and preclinical colleagues. I am well aware of the importance of BAP in providing informal support and mentorship especially to younger members starting out in their careers. For the last 12 years I have been actively involved in a wide range of BAP teaching programmes - I taught on the Masterclass in Schizophrenia 2007-2012; was Scientific Editor for its on-line CPD module until 2012; was Course Organiser for the Schizophrenia Module of the Clinical Certificate from 2012 to 2017; and since 2014 I have also taught on the Affective Disorders Certificate Module and Depression Masterclass. Being on Council has given me an insight into the workings of the association and the importance of the huge amount of work necessary behind the scenes. I am delighted to be able to serve the BAP further as Honorary General Secretary.
My work as an academic involved in clinical and basic science research, plus my clinical work as an Honorary NHS Consultant, means I am well placed to represent the full BAP membership as Honorary General Secretary. Membership numbers are static and even falling across a range of professional associations, and I intend to work hard to assist the President, Council and Executive Officer with plans to maintain and expand the BAP’s membership. Keeping effective records and upholding the necessary legal requirements are important parts of the role and I believe I can bring enthusiasm and attention to detail to the post. I will continue to work to promote and maintain the role of the BAP as provider of choice for high-quality information, education and training for clinicians at all levels – as well as to patients, carers and the public. One of the BAP’s very great strengths is its multidisciplinary nature – Clinical Psychiatry, Pharmacy, Preclinical and Industry. I believe that good medicine needs strong collaboration between these disciplines of the highest scientific and ethical standards, and I will be active in seeking to maintain and promote this cross-disciplinary interaction among the membership.
Declaration of Interests
- Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
- Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
- Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
- Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
- In 2018 I received consultancy fees as an Advisory Board member for LivaNova UK Ltd, a medical device company in the field of clinical neuroscience.
- Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
- Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
- Have you, in the past three years, had membership of the speakers' bureau for any company?
- Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
- Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
- Have you, in the past three years, recruited patients for industry-sponsored studies?
- Since 2018 I have been PI on a clinical drug trial sponsored by COMPASS Pathways Ltd, UK, in my capacity as Honorary Consultant Psychiatrist with Greater Manchester Mental Health NHS Foundation Trust. I receive no payment from the company. Costs for my time on the study are paid to my Trust.
- If there is anything else you feel it necessary to disclose, please provide details below:
Form completed on 23rd July 2019